Search

Ushering in a new era in cancer care in Fort Worth, UT Southwestern Medical Center broke ground today on a $177 million Radiation Oncology campus that will provide the most advanced therapies for patients of the nation’s 12th largest city.

Most days, neurologist Sasha Alick-Lindstrom, M.D., M.P.H., FAAN, FACNS, FAES, can be found staring at rows of brain signals on multiple computer screens, inspecting the squiggly lines for any irregularities or spikes of electrical activity.

UT Southwestern Medical Center is the first facility in Dallas and the surrounding region to participate in the international COLCORONA trial.

UTSW research finds significant disparities exist in diagnosing and treating headaches by race, socioeconomic level, and insurance status.

A study that identifies how a coronavirus protein called Nsp1 blocks the activity of genes that promote viral replication provides hope for new COVID-19 treatments.

Read past stories about the extraordinary work being done and the passionate people behind it.

Artificial intelligence may soon play a critical role in choosing which depression therapy is best for patients.

A first-in-kind kidney cancer drug developed from laboratory and translational studies conducted at UT Southwestern Medical Center received approval from the Food and Drug Administration, providing a new treatment for patients with familial kidney cancer.

Dr. Stephanie Tow, M.D., completed her first week of providing volunteer care at the Tokyo 2020 Olympics.

The Harold C. Simmons Comprehensive Cancer Center at UT Southwestern earned exemplary marks as part of the renewal of its comprehensive designation by the National Cancer Institute (NCI).